Search Results 1-10 of 16755 for GLP-1 agonists

  1. Diabetes drugs and weight loss - Mayo Clinic

    Tirzepatide (Mounjaro) is a similar kind of medicine called a dual-acting GLP-1/GIP agonist. It's also used to control blood sugar and can support weight loss.

  2. A Study Of GLP-1 Receptor Agonists On Reproductive Health In Women - Mayo Clinic

    ... GLP-1 agonists during their reproductive years. To understand the efficacy each available GLP-1 agonist or dual agonist may have on reproductive health.

  3. Preoperative Gastric Content With Ultrasound Assessment in Patients Taking GLP1 Agonists - Mayo Clinic

    ... glucagon-like peptide 1 (GLP-1) agonist medications compared to patients who do not take GLP-1 agonists. Participation eligibility. Participant eligibility ...

  4. Evaluation of the changes in glycemic and physiologic parameters (sleep, cardioadapatbility parameters) in non-diabetic patients being treated for obesity with GLP1 Agonist and GLP-1/ GIP agonist medications. - Mayo Clinic

    ... GLP1 Agonist and GLP-1/ GIP agonist medications. ... It is proposed that participants will wear the devices for a period of 28 days before the initiation of GLP-1 ...

  5. Effects Of Long-Acting GLP-1 (Glucagon-like Peptide-1) Or Dual Incretin (GLP-1 And GIP [Glucose-dependent Insulinotropic Peptide]) Modulation On Gastric Motor Functions - Mayo Clinic

    * Patients with T2DM on GLP-1RAs, amylin agonists/analogs (e.g. pramlintide), insulin, sulfonylureas (all due to risk of hypoglycemia with semaglutide or ...

  6. Examining the impact of GLP-1 receptor agonist use on quality of bowel preparation for colonoscopy - Mayo Clinic

    "Our study found that patients using GLP-1 receptor agonists are more likely to have inadequate bowel preparation during colonoscopy, even when we account for ...

  7. GLP-1RA and thyroid cancer: New study suggests detection bias, not causation - Mayo Clinic

    Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are cornerstone therapies for type 2 diabetes, obesity and cardiovascular health.

  8. Effect of GLP-1 Receptor Agonism After Sleeve Gastrectomy - Mayo Clinic

    In this study the investigators propose to randomize subjects undergoing SG to receive either placebo or Liraglutide, a GLP-1 receptor agonist, to compare ...

  9. Semaglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is also used together with diet and exercise to help lose weight ...

  10. Prescription weight-loss drugs - Mayo Clinic

    FDA's concerns with unapproved GLP-1 drugs used for weight loss. ... https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas- ...